Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 6—June 2025

Dispatch

Prevalence of Nitroimidazole-Refractory Giardiasis Acquired in Different World Regions, Sweden, 2008–2020

Karin A. YdstenComments to Author , Joanna Nederby Öhd, Urban Hellgren, and Hilmir Asgeirsson
Author affiliation: Capio St. Görans Hospital, Stockholm, Sweden (K.A. Ydsten); Karolinska University Hospital, Stockholm (K.A. Ydsten, U. Hellgren, H. Asgeirsson); Region Stockholm, Stockholm (J.N. Öhd); Karolinska Institutet, Stockholm (U. Hellgren, H. Asgeirsson)

Main Article

Table

Prevalence of giardiasis by country of acquisition and rate of nitroimidazole-refractory cases, Stockholm, Sweden, 2008–2020

Origin of infection* Total no. cases No. (%) nitroimidazole-refractory cases
Asia 1,337 73 (5.5)
India 545 64 (11.7)†
Thailand 168 4 (2.4)
Pakistan 94 1 (1.1)
Iraq 71 0
Turkey 65 0
Afghanistan 58 0
Syria 45 0
China 36 0
Sri Lanka 33 0
Cambodia 25 0
Indonesia 25 0
Bangladesh 23 2 (8.7)
Nepal
7
2 (28.6)
Africa 1,115 17‡ (1.5)
Tanzania 136 3 (2.2)
Somalia 133 1 (0.8)
Ethiopia 105 1 (0.9)
Kenya 94 0
Eritrea 93 0
Uganda 65 2 (3.1)
Egypt 57 0
Gambia 45 0
Sudan 37 0
South Africa 26 1 (3.8)
Morocco
23
0
Americas 349 1 (0.3)
Colombia 67 1 (1.5)
Brazil 55 0
Peru 36 0
Mexico 28 0
United States
23
0
Europe 1,247 11§ (0.9)
Sweden 881 5 (0.6)
Spain 107 2 (1.9)
Greece 36 0
France
29
1 (3.4)
Oceania
5
0
Unknown
232
0
Total 4,285 102 (2.4)

*Countries with >20 giardiasis cases in total are shown, as well as countries with >2 treatment refractory cases. †p<0.0001 for India compared with rest of Asia and for India compared with the rest of the world (by χ2 test). ‡In addition, the following countries had 1 case: Angola, Benin, Central African Republic, Democratic Republic of the Congo, Ghana, Madagascar, Sudan, Tchad, and Zimbabwe. §In addition, the following countries had 1 case: Belgium, Italy, and Switzerland.

Main Article

Page created: April 21, 2025
Page updated: May 16, 2025
Page reviewed: May 16, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external